Allergen-specific Th2 cells as targets for immune intervention in allergic disease

Allergology International

Volumn 45, Issue 3, 1996, Pages 117-123

  de Vries, Jan E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

allergen specific Th2 cells; IgE synthesis; IL 4 and IL 13 receptor antagonist; inhibition of allergic responses; Th2 cell anergy; Th2 cell differentiation

Indexed keywords

EID: 85010123829     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.45.117     Document Type: Review

References (56)

1. Péne, J, Rousset, F, Briere, F et al. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc. Natl Acad. Sci. USA 1988; 85:, 6880–4
2. Punnonen, J, Aversa, G, Cocks, BG et al. Interleukin 13 induces interleukin 4-independent lgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl Acad. Sci. USA 1993; 90: 3730–4
3. Spriggs, MK, Armitage, RJ, Stockbine, L et al. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion J. Exp. Med. 1992; 176: 1543–50
4. Punnonen, J, de Vries, JE. IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells. J. Immunol. 1994; 152: 1094–202
5. Wierenga, EA, Snoek, M, de Groot, C et al. Evidence for compart-mentalization of functional subsets of CD4+T lymphocytes in atopic patients. J. Immunol. 1990; 144: 4651–6
6. Parronchi, P, Macchia, D, Piccinni, MP et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad. Sci. USA 1991;88:, 4538–42
7. Yssel, H. Johnson, KE. Schneider, PV et al. T cell activation-inducing epitopes of the house dust mite allergen Der pl. Proliferation and lymphokine production patterns by Der pl-specific CD4+ T cell clones. J. Immunol. 1992; 148: 738–45
8. Carballido, JM, Carballido-Perrig, N, Terres, G, Heusser, CH, Blaser, K. Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: Cytokine patterns change in response to the antigen concentration. Eur. J. Immunol. 1992; 22: 1357–63
9. Sager, N, Feldmann, A, Schilling, G, Kreitsch, P, Neumann, C. House dust-mite-specific T cell in the skin of subjects with atopic dermatitis: Frequency and lymphokine profile in the allergen patch test. Eur. J. Dermatol. 1992; 89: 801–10
10. Ebner, C, Schenk, S, Najafian, N et al. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J. Immunol. 1995; 154: 1,932–40
11. Kay, AB, Ying, S, Varney, V et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med. 1991; 173: 775–8
12. Hamid, Q. Azzawi, M, Ying, S et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest 1991; 87: 1541–6
13. Robinson, DS, Hamid, Q, Ying, S et al. Predominant Th2-like bron-choalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 1992,326: 298–304
14. Bradding, P, Feather, IH, Wilson, S. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J. Immunol. 1993; 151: 3853–65
15. Del Prete, G, De Carli, M, Almerigogna, F, Romagnani, S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 1993; 150: 353–60
16. Rousset, F, Robert, J, Andary, M et al. Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J. Allergy Clin. Immunol. 1991; 87: 58–69
17. Mosmann, TR, Coffman, RL. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989; 7: 145–73
18. Romagnani, S. Lymphokine production by human T cells in disease states. Ann. Rev. Immunol. 1994; 12: 227–57
19. Lamb, JR, Zanders, ED, Sewell, W, Crumpton, MJ, Feldmann, M, Owen, MJ. Antigen-specific T cell unresponsiveness in cloned helperT cells mediated via the CD2 or CD3/Ti receptor pathways. Eur. J. lmmunol. 1987; 17: 1641–4
20. Fasler, S, Aversa, G, Terr, A, Thestrup-Pedersen, K, de Vries, JE, Yssel, H. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B-cell help for IgE synthesis: Reversal by IL-2, not by IL-4 or IL-13. J. Immunol. 1995; 155: 4199–206
21. Fraser, JD, Irving, BA, Crabtree, GR, Weiss, A. Regulation of interleukin-2 gene enhancer activity of the T cell accessory molecule CD28. Science 1991; 251: 313–16
22. Freeman, GJ, Freedman, AS, Segil, JM, Lee, G, Whitman, JF, Nadler, LM. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 1989; 143: 2714–22
23. Linsley, P.S., Brady, W, Grosmaire, L, Aruffo, A, Damle, N.K., Ledbetter, J.A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and IL-2 mRNA accumulation. J. Exp. Med. 1991; 173: 721–30
24. Azuma, M, Ito, D, Yagita, H et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366: 76–9
25. La Salle, JM, Toneguzzo, F, Saadeh, M, Golan, DE, Taber, R, Hafler, DA. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigens and autoantigens. J. Immunol. 1993; 151: 649–57
26. Wraith, DC, Smilek, DE, Mitchell, DJ, Steinman, L, McDevitt, HO. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 1989; 59: 247–55
27. Gaur, A, Weirs, B, Liu, A, Rothbard, J, Fathman, CG. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-inducing anergy. Science. 1992; 258: 1491–4
28. Romball, CG, Weigle, WO. In vivo induction of tolerance in murine CD4+T cell subsets. J. Exp. Med. 1993; 178: 1637–44
29. Briner, TJ, Kuo, MC, Keating, KM, Rodgers, BL, Greenstein, JL. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. Proc. Natl Acad. Sci. USA 1993; 90: 7608–12
30. Critchfield, JM, Racke, MK, Züniga-Pflücker, JC. T-cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994; 263: 1139–43
31. Secrist, H, Chelen, CJ, Wen, Y, Marshall, JD, Umetsu, DT. Allergen immunotherapy decreases interleukin-4 production in CD4+ T cells from allergic individuals. J. Exp. Med. 1993; 178: 2123–30
32. Gammon, G, Shastri, N, Cogserll, J et al. The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site. Immunol. Rev. 1987; 98: 53–73
33. Adorihi, L, Appella, E, Doria, G, Nagy, ZA. Mechanisms influencing the immunodominance of T cell determinants. J. Exp. Med. 1988; 168: 2091–104
34. Perkins, DL, Berriz, G, Kamradt, T, Smith, JA, Gefter, ML. Immunodominance: intramolecular competition between T cell epitopes. J. Immunol. 1991; 146: 2137–44
35. Gammon, G, Sercarz, E. How some T cells escape tolerance induction. Nature 1989; 342: 183–5
36. Hsieh, CS, Heimberger, AB, Gold, JS, O'Garra, A, Murphy, KM. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc. Natl Acad. Sci. USA 1992; 89: 6065–9
37. Seder, RA, Paul, WE, Davis, MM, de St. Groth, BF. The presence of interleukin-4 during in vivo priming determines the lymphokine-producing potential of CD4+ T celIs from T cell receptor transgenic mice. J. Exp. Med. 1992; 176: 1091–8
38. Hsieh, CS, Macatonia, SE, Tripp, CS, Wolf, SF, O'Garra, A, Murphy, KM. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260: 547–9
39. Seder, RA, Gazzinelli, R, Sher, A, Paul, WE. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl Acad. Sci. USA 1993; 90: 101: 88–92
40. Alfonso, LC, Scharfon, TM, Vieira, LQ, Wysocka, M, Trinchieri, G, Scott, P. The adjuvant effect of interleukin-1 2 in a vaccine against Leishmania major. Science 1994; 263: 235–7
41. Manetti, R, Gerosa, F, Giudizi, MG et al. Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J. Exp. Med. 1994; 179: 1273–83
42. Yssel, H, Fasler, S, de Vries, JE, de Waal Malefyt, R. IL-12 transiently induces IFN-gamma transcription and protein synthesis in human CD4+ allerqen-specific Th2 T cell clones. Int. Immunol. 1994; 6: 1091–6
43. Parronchi, P, De Carli, M, Manetti, R et al. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 1992; 149: 2977–83
44. Manetti, R, Parronchi, P, Giudizi, M G et al. Natural kilbrcell stimulatory factor (interleukin 12 [1L-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 1993; 177: 1199–204
45. Sornasse, T, Larenas, PV, Davis, KA, de Vries, JE, Yssel, H. Differentiation and stability of Thl and Th2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single cell level, J. Exp. Med. (In press).
46. de Waal Malefyt, R, Figdor, CG, Huijbens, R ef al. Effects of IL-13 on phenotype, cytokine production and cytotoxic function of human monocytes-comparison with IL-4 and modulation by IGN-y or IL-10. J. Immunol. 1993; 151: 6370–81
47. Perez, VL, Lederer, JA, Lichtman, AH, Abbas, AK. Stability of T(h) 1 and T(h)2 populations. Int. Immunol. 1995; 7: 869–75
48. Szabo, SJ, Jacobson, NG, Dighe, AS, Gubler, U, Murphy, KM. Developmental commitment to the Th2 linage by extinction of IL-signaling. Immunity 1995; 2: 665–75
49. Nabors, GS, Afonso, LC, Farrell, JP, Scott, P. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc. Natl Acad. Sci. USA 1995; 92: 3142–6
50. Cocks, BG, Chang, C-CJ, Carballido, JM, Yssel, H, de Vries, JE, Aversa, G. A novel receptor involved in T-cell activation. Nature 1995; 376:, 260–3
51. Seder, RA, Paul, WE, Dvorak, AM et al. Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils. Proc. Natl Acad. Sci. USA 1991; 88: 2835–9
52. Bradding, P. Feather, IH, Howarth, PH et al. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 1992; 176: 1381–6
53. Brunner, T, Heusser, CH, Dahinden, CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med. 1993; 177: 605–11
54. Schmitz, J, Thiel, A, Kuhn, R et al. Induction of interleukin 4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-Th cells. J. Exp. med. 1994; 179: 1349–53
55. Yoshimoto, T, Paul, WE. CD4+, NK1.1+ T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 1994; 179: 1285–95
56. Marsh, DG, Neely, JD, Breazeale, DR et al. Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994; 264: 1152–6